Back

Risk-based thresholds enable efficient allocation of GLP-1 receptor agonists in atherosclerotic cardiovascular disease without diabetes

30 August 2026 (09:27 - 09:45)
Organised by: Logo
Congress Presentation Part of: Cardio-renal-metabolic syndrome: the triple threat Secondary Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Steven Hageman

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on cardio-renal-metabolic syndrome
Professor N. Marx (Aachen, DE)
Slides Video
Presentation thumbnail
Cardiovascular risk emerges below the diagnostic threshold for diabetes: insights from the Western Denmark Heart Registry
Doctor K. Olesen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Association of clonal hematopoiesis with cardiovascular-kidney-metabolic syndrome in 434,000 individuals
Ms A. Chang (US)
Abstract Slides Video
Presentation thumbnail
Sex differences in excess risk of cardiovascular disease and mortality among patients with type 2 diabetes: a matched register-based cohort study
Associate Professor C. Lundberg (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-renal-metabolic syndrome: the triple threat
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 09:27 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Science: cardiometabolic medicine
31 August 2025
thumbnail
Congress Presentation
Risk of cardiovascular events in U.S. patients using the SMART risk score
30 August 2025
thumbnail
Congress Presentation
Addressing the clinical challenge: how to choose the optimal therapy?
29 August 2022
thumbnail
Congress Presentation
Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources